TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders | MicrobiomeTrials← Back to trialsNCT07377032
TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-08-29Est. Completion: 2028-06
Enrollment target: 40 participants Locations- Hospices Civils de Lyon, Lyon, France
- Meyer Children's Hospital, Florence, Italy
- Children's Memorial Health Institute, Warsaw, Poland
Other microbiome trials you might be interested in
GRIN-related Neurodevelopmental Disorder
The Phase 3 portion of Study RAD-GRIN-101 is a multinational, multicenter, randomized, double-blind, placebo-controlled …
Los Angeles, United StatesEst. completion May 2027
Hepatic Impairment
This Phase 1, open-label study will evaluate the pharmacokinetics (PK), safety, and tolerability of a single oral dose o…
DeSoto, United StatesEst. completion May 2027
Phase 1
Recruiting
Tuberous Sclerosis ComplexFocal Cortical Dysplasia
Study RAD-GRIN-201 is a phase 1B/2A trial to assess safety, tolerability, pharmacokinetics (PK), and potential efficacy …
South Brisbane, AustraliaEst. completion Jun 2026